Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hetzer Medical Indonesia Tbk. (MEDS) vs Saraswanti Indoland Development Tbk. (SWID) Price & Performance

Hetzer Medical Indonesia Tbk.Trade
Saraswanti Indoland Development Tbk.Trade

Price performance (Past 24H)

Key statistics

Hetzer Medical Indonesia Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp82 (market cap 126.56B, 319.74M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp91 (market cap 500.81B, 1.26M 24h volume). The key difference: Saraswanti Indoland Development Tbk. is far larger — about 4× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (319.74M versus 1.26M). Which is the better fit depends on your goals.

MEDSSWID
Market Cap
126.56B500.81B
Volume
319.74M1.26M
Lot
3.2M12.61K
Turnover
27.4B113.99M
Average Price
85.6890.38
Value
27.4B113.99M
Indicative Equilibrium Price
8291
Indicative Equilibrium Volume
12.79K643

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MEDS
View details
SWID
View details

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS

About Saraswanti Indoland Development Tbk.

PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.

Read more on SWID